Wendy Becker to join GSK board as Non-Executive Director
London: GSK plc has announced that Wendy Becker will join the Board of the Company as a Non-Executive Director with effect from 1 October 2023.
On joining the Board, Wendy will become a member of the Company’s Remuneration Committee. She will succeed Urs Rohner as Chair of the Remuneration Committee after the Company’s 2024 Annual General Meeting when Urs steps down on completion of his nine years’ service to the Board.
Wendy is currently Chair of Logitech International S.A., and a Board member and Chair of the Compensation Committee of Sony Group Corporation. She has strong executive management experience including senior roles at McKinsey & Company, TalkTalk, and Vodafone and as CEO at Jack Wills. Within the life sciences sector, Wendy is a Board member and Chair of the Remuneration Committee of Oxford Nanopore Technologies plc. She is a member of the governing bodies of the University of Oxford and related subsidiaries.
Commenting on Wendy’s appointment, Sir Jonathan Symonds, Chair of GSK said, “I am delighted to welcome Wendy to GSK. Wendy is a highly experienced non-executive director, and has held significant leadership positions in a wide range of global businesses, including several in the technology and life sciences sectors. I’m sure she will make a significant contribution to the Board and we look forward to her joining in October.”
Read also: GSK HIV prevention drug gets European Commission authorisation
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd